Come up with a name for your new list and we'll add to it:
Envoy Therapeutics raised a round of funding on November 16, 2010. Investors include
Qualifying Therapeutic Discovery Project.
Envoy Therapeutics aims to discover new drugs with efficacy and fewer side effects than existing treatments. The companys bacTRAP technology enables the identification of proteins in vivo that are pro…